Postoperative changes in left ventricular systolic function after combined mitral and aortic valve replacement in

Sang-Mee An1, Jae-Sik Nam2, Ho Jin Kim3

  • 1Department of Anesthesiology and Pain Medicine, Ewha Womans University Seoul Hospital, Seoul, South Korea.

Insights

In rheumatic heart disease (RHD) patients undergoing valve replacement, left ventricular ejection fraction (LVEF) initially stabilizes. Long-term LVEF trends differ based on preoperative function, showing a plateau in normal LVEF and a decline in reduced LVEF.

Area of Science:

  • Cardiology
  • Cardiac Surgery
  • Echocardiography

Background:

  • Rheumatic heart disease (RHD) affects heart valves, often necessitating combined aortic and mitral valve replacement.
  • Postoperative left ventricular systolic function is crucial for patient outcomes after valve surgery.

Purpose of the Study:

  • To investigate short- and long-term changes in left ventricular systolic function after combined aortic and mitral valve replacement in RHD patients.
  • To compare these changes based on preoperative left ventricular ejection fraction (LVEF).

Main Methods:

  • Analysis of 146 RHD patients undergoing combined valve replacement.
  • Stratification into two groups based on preoperative LVEF: ≥50% (n=113) and <50% (n=33).
  • Utilized a restricted cubic spline model to analyze time-dependent changes in echocardiographic parameters.

Main Results:

  • No significant difference in LVEF was observed preoperatively or immediately postoperatively before discharge.
  • In patients with preoperative LVEF ≥50%, LVEF slightly increased and plateaued during a median follow-up of 3.2 years.
  • In patients with preoperative LVEF <50%, LVEF increased over 3-4 years before gradually declining (p < .001).

Conclusions:

  • Long-term postoperative LVEF demonstrates a downward trend in RHD patients with initially reduced LVEF.
  • In RHD patients with normal preoperative LVEF, long-term postoperative LVEF tends to stabilize or plateau.
Abstract

Related Concept Videos

Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
100
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
112
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
63
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
91
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
71
Mitral Stenosis IV: Nursing Management01:27

Mitral Stenosis IV: Nursing Management

A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
91